(Washington, DC / August 1, 2011) Baker, Donelson, Bearman, Caldwell & Berkowitz, PC has expanded its Intellectual Property Practice Group with the addition of Dr. Richard E.L. Henderson* in its Washington, D.C. office. Dr. Henderson joins the Firm as of counsel.

"With 30 years of experience at leading organizations in the biotechnology and pharmaceutical sectors, Dr. Henderson has established an outstanding reputation in patent law," said W. Edward Ramage, chair of Baker Donelson's Intellectual Property Group. "His addition is a tremendous asset to our Intellectual Property team and to our clients in these industries."

John G. Calender, managing shareholder of the Firm's Washington, D.C. office, added, "We're pleased to welcome an attorney of Dr. Henderson's caliber to Baker Donelson. He is the latest in a number of notable additions to the Life Sciences practice of our Intellectual Property team, which has grown significantly in recent years."

Prior to joining Baker Donelson, Dr. Henderson served as senior patent counsel and head of the patent group for nine years at Bayer CropScience LP and as patent counsel for 14 years at Bayer Corporation, where he was responsible for intellectual property matters for Bayer's Industrial Chemicals Division. Prior to Bayer, he worked as a patent attorney with Merck and a patent agent with G. D. Searle. Dr. Henderson has significant experience in patent prosecution; the preparation and negotiation of agreements including license, consulting and secrecy agreements; trademark review and prosecution; and other intellectual property issues such as patentability, validity and infringement opinions.

A graduate of the Chicago-Kent College of Law, Dr. Henderson holds a Ph.D. in organic chemistry from the University of Illinois at Urbana-Champaign.

*Not admitted to practice in D.C. Practice limited to matters and proceedings before federal courts and agencies.